Top 5 News Stories 9/29 – 10/5
1) MassBio speaks out on zoning proposal Mass High Tech – 10/02/2012
The Massachusetts Biotechnology Council (MassBio), on behalf of its more than 600 members, has asked city officials in Cambridge to vanquish a downzoning proposal submitted by neighborhood activists and residents of Central Square. Link
2) Maker of exoskeleton medical devices comes to Marlborough MetroWest Daily News – 10/05/2012
The CEO of an Israeli manufacturer of medical devices that help paraplegics to walk said he is excited to establish the company’s U.S headquarters in Marlborough.”Massachusetts has become a remarkably good cluster for life sciences,” said Larry Jasinski, CEO of Argo Medical Technologies Ltd. Link
3) Addgene partners with Michael J. Fox Foundation Mass High Tech – 10/03/2012
Non-profit biotech lab Addgene has teamed up with The Michael J. Fox Foundation to pull together a collection of plasmid DNA samples to be used in Parkinson’s Disease research. Link
4) MIT economist pitches cancer megafund Boston.com– 10/01/2012
Andrew W. Lo, the MIT finance professor and hedge fund manager, wants to bring Wall Street-style financial engineering to a crucial social need: curing cancer. Named this year as one of Time magazine’s 100 most influential people in the world, Lo runs an investment firm in Cambridge called AlphaSimplex Group, with $3 billion in assets. Link
5) GnuBIO secures $10M in equity Mass High Tech – 10/02/2012
Almost two years after a $8 million Series A round, genetic sequencing company GnuBIO Inc. in Cambridge has received $10 million in equity financing, according to federal filings Tuesday. Link
Posted on October 5, 2012, in MassBio, News Roundup and tagged Addgene, ARGO Medical Technology, City of Cambridge, GnuBIO, Marlborough, Michael J. Fox Foundation, MIT, Parkinson's Disease. Bookmark the permalink. Leave a Comment.


Leave a Comment
Comments (0)